Cooperative Spin Amplifier for Enhanced Quantum Sensing
Physical Review Letters · 26.09.2024 · 133 (13)
DOI: 10.1103/physrevlett.133.133202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Review Letters, online erschienen am 26.09.2024. Verfasst von Minxiang Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Microscale Magnetic Resonance and School of Physical Sciences, University of Science and Technology of China, Hefei 230026, Chi…. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Youth Innovation Promotion Association of the Chinese Academy of Sciences, Innovation Program for Quantum Science and Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- CAS Key Laboratory of Microscale Magnetic Resonance and School of Physical Sciences, University of Science and Technology of China, Hefei 230026, China; Anhui Province Key Laboratory of Scientific Instrument Development…
Förderung
- National Natural Science Foundation of China
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
- Innovation Program for Quantum Science and Technology
- Chinese Academy of Sciences Magnetic Resonance Technology Alliance Research Instrument
Zitieren
APA
Xu, M., Jiang, M., Wang, Y., Su, H., Huang, Y., & Peng, X. (2024). Cooperative Spin Amplifier for Enhanced Quantum Sensing. Physical Review Letters, 133(13). https://doi.org/10.1103/physrevlett.133.133202
Vancouver
Xu M, Jiang M, Wang Y, Su H, Huang Y, Peng X. Cooperative Spin Amplifier for Enhanced Quantum Sensing. Physical Review Letters. 2024;133(13). doi:10.1103/physrevlett.133.133202
BibTeX
@article{Xu2024,
author = {Xu, Minxiang and Jiang, Min and Wang, Yuanhong and Su, Haowen and Huang, Ying and Peng, Xinhua},
title = {Cooperative Spin Amplifier for Enhanced Quantum Sensing},
journal = {Physical Review Letters},
year = {2024},
volume = {133},
number = {13},
doi = {10.1103/physrevlett.133.133202}
}
EUVIMED